SCHEMBL5952437

SCHEMBL5952437

CC(C)C(C)B(Cc1ccccc1)C(C)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.43
TRPA1 O75762 3/20 0.42
TAAR1 Q96RJ0 5/20 0.41
SIGMAR1 Q99720 4/20 0.41
SLC6A2 P23975 3/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
MAOA P21397 1/20 0.41
CYP2A6 P11509 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
SLC18A2 Q05940 1/20 0.39
TP53 P04637 1/20 0.39
CALM1 P0DP23 1/20 0.36
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
HTR2A P28223 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRK1 P41145 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19066702 0.67 TAAR1 (0.56) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL12400987 0.67 TP53 (0.48) TRPA1TAAR1SIGMAR1SLC6A2SLC6A4
SCHEMBL30934 0.67 TRPA1 (0.77) CYP2D6TRPA1TAAR1SIGMAR1SLC6A2
SCHEMBL5952618 0.67 TSHR (0.41) CYP2D6TRPA1TAAR1SIGMAR1SLC6A2
SCHEMBL555907 0.66 CALM1 (0.50) TRPA1TAAR1MAOACYP2A6TP53
SCHEMBL1140503 0.65 TRPA1 (0.74) CYP2D6TRPA1TAAR1SIGMAR1SLC6A2
Water SCHEMBL3896311 0.65 TRPA1 (0.74) CYP2D6TRPA1TAAR1SIGMAR1SLC6A2
SCHEMBL14114754 0.65 SIGMAR1 (0.40) CYP2D6TRPA1TAAR1SIGMAR1SLC6A2
SCHEMBL24101775 0.64 LOXL2 (0.43) CYP2D6TRPA1TAAR1SIGMAR1SLC6A2
SCHEMBL21063908 0.64 TSHR (0.43) TRPA1TAAR1SIGMAR1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1762957-B 2,3-dihydro-1-indene compound and preparation method thereof BASELL POLYOLEFINE GMBH 2010-05-12 CN disclosed
CN-100451024-C Metallocene compound, indene compound and application thereof BASELL POLYOLEFINE GMBH (DE) 2009-01-14 CN disclosed
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
CN-1762957-A 2,3-dihydro-1-indene compound and preparation method thereof BASELL POLYOLEFINE GMBH (DE) 2006-04-26 CN disclosed
CN-1763060-A Metallocene compound, indene compound and application thereof BASELL POLYOLEFINE GMBH (DE) 2006-04-26 CN disclosed
CN-1231431-C Process for preparing substituted 2, 3-dihydro-1-indanones TARGOR GMBH (DE) 2005-12-14 CN disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
CN-1254328-A Process for preparing substituted 2, 3-dihydro-1-indanones TARGOR GMBH (DE) 2000-05-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A CYP2D6 16/4885TRPA1 3969/4885TAAR1 3746/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 CYP2D6 15/4885TRPA1 3711/4885TAAR1 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.